Nasal Drug Delivery Market Growth, Trends, Revenue, Share, Research Report Forecast till 2026

The global Nasal Drug Delivery Market size is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.

visit: https://www.fortunebusinessinsights.com/industry-reports/nasal-drug-delivery-devices-market-100415

List of Known Nasal Drug Delivery Technology Market Manufacturers include:

Consort Medical plc. (United Kingdom)
Teva Pharmaceutical Industries Ltd.
H&T Presspart Manufacturing Ltd.
3M
GOFIRE INC.
Nemera
AptarGroup, Inc. (United States)
Vectura Group plc (United Kingdom)
Others

Rising Awareness About Nasal Spray and its Benefits will Help Market Gain Impetus

The increasing prevalence of respiratory disorders among people is a major factor boosting the Nasal Drug Delivery Market growth. Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. Besides this, analyst at Fortune Business Insights™ says, “The increasing patient population and the rising demand for inhalers are encouraging companies to set up new manufacturing units. This is further expected to drive the overall market in the forecast period.”

Europe to Dominate Owing to Rising Prevalence of Asthma

Geographically, the global Nasal Drug Delivery Market is categorized into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. Among these, Europe is holding the largest share with a nasal drug delivery technology market revenue of USD 21.1 billion in 2018. This dominance is attributable to the increasing prevalence of asthma, coupled with the rise in awareness about nasal sprays and their benefits. Besides this, there is the rising popularity of inhalers in developing nations of this region, thereby boosting the regional market.

More Trending Topics from Fortune Business Insights:

https://www.fortunebusinessinsights.com/industry-reports/adas-market-101897

https://www.fortunebusinessinsights.com/automotive-turbocharger-market-102663